Clinical Trial Update: SakuraBead Used as Resorbable Embolic for Plantar Fascia Embolization [NA]

View source ↗

Summary

A clinical trial is evaluating SakuraBead as a resorbable embolic agent for plantar fascia embolization, and the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plantar Fasciitis

Snippet

Sponsor: CrannMed | Conditions: Plantar Fascitis, Heel Pain | NA | Status: RECRUITING